This Q&A guideline concerns the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic medicinal products. It addresses the electrocardiogram methodology, gender, positive control, study design, use of concentration response modeling of QTc data and electrocardiogram monitoring in late stage clinical trials.
Read the pdf